Document is current
Any future updates will be listed below
-
Authors
Gao, Hongmei
Peng, Miaolian
Zhong, Rongzhi
Xue, Zhenhua
Liu, Zhenqiang
Weng, Shiqiao
Zhang, Longchao
Wang, Dong
Liu, Yan
Tian, Jianhui
Wang, Lixian
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2022YFD1300302, 2022YFD1300302, 2022YFD1300302, 2022YFD1300302, 2022YFD1300302, 2017YFD0501901, 2022YFD1300302, 2017YFD0501901)
Agricultural Science and Technology Innovation Program (ASTIP-IAS02, ASTIP-IAS02, ASTIP-IAS02)
- License Information
-
More Information
Article History
Received: 28 December 2024
Accepted: 25 March 2025
First Online: 16 April 2025
Declarations
:
: All animals were treated humanely according to the criteria outlined in the “Guide for the Care and Use of Laboratory Animals” published by the Institute of Animal Sciences, Chinese Academy of Agricultural Sciences (Beijing, China). The experimental protocols used in this study were approved by the Animal Care and Use Committee (No. IAS2022‐79).
: Not applicable.
: The cloprostenol sodium and carbetocin utilized in this study was sponsored by Ningbo Sansheng Biological Technology Co., Ltd.
